Adial Pharmaceuticals (ADIL) Other Working Capital Changes (2021 - 2023)
Adial Pharmaceuticals (ADIL) posted Other Working Capital Changes of -$13579.0 for Q1 2023, down 5.48% sequentially from -$12874.0 in Q4 2022, and down 14.96% YoY from -$15967.7 in Q1 2022.
Adial Pharmaceuticals (ADIL) Other Working Capital Changes (2021 - 2023) Analysis & Trends
Adial Pharmaceuticals has reported Other Working Capital Changes for 3 years, with the latest figure at -$13579.0 in Q1 2023.
- Quarterly Other Working Capital Changes fell 14.96% year-over-year to -$13579.0 in Q1 2023, while the trailing twelve-month figure through Mar 2023 was -$51352.0 (changed N/A YoY) and the FY2022 annual result came in at -$49585.0, down 32.8% from the prior year.
- Other Working Capital Changes eased to -$13579.0 in Q1 2023 per ADIL's latest filing, from -$12874.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $378237.0 in Q3 2023 and troughed at -$154798.0 in Q4 2022.
- A 5-year average of -$19253.1 and a median of -$86756.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes slumped 141.21% in 2022, then retreated 14.96% in 2023.
- Over 3 years, Other Working Capital Changes stood at -$11108.0 in 2021, then fell by 15.9% to -$12874.0 in 2022, then decreased by 5.48% to -$13579.0 in 2023.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$13579.0, -$12874.0, and -$12589.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Adial Pharmaceuticals | 27.59 Mn | 27.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -13,579.00 |
| Mar 31, 2023 | -13,579.00 |
| Mar 31, 2023 | -13,579.00 |
| Dec 31, 2022 | -12,874.00 |
| Dec 31, 2022 | -12,874.00 |
| Dec 31, 2022 | -12,874.00 |
| Sep 30, 2022 | -12,589.00 |
| Sep 30, 2022 | -12,589.00 |
| Sep 30, 2022 | -12,589.00 |
| Jun 30, 2022 | -12,310.00 |
| Jun 30, 2022 | -12,310.00 |
| Jun 30, 2022 | -12,310.00 |
| Mar 31, 2022 | -11,812.00 |
| Mar 31, 2022 | -11,812.00 |
| Mar 31, 2022 | -11,812.00 |
| Dec 31, 2021 | -11,108.00 |
| Dec 31, 2021 | -11,108.00 |
| Dec 31, 2021 | -11,108.00 |
| Sep 30, 2021 | -5,219.00 |
| Sep 30, 2021 | -5,219.00 |